- 4601. Amifostine/Ciprofloxacin/Pentoxifylline
- (UMLS (NCI) C0677759) =Therapeutic or Preventive Procedure
| - 4651. aminoacid analog
- [synthetic or natural compounds which resemble naturally occurring amino acids in structure and/or function. ( CSP )] (UMLS (CSP) C0178472) =Amino Acid, Peptide, or Protein =analog;
=biocytin;
phenylalanine analog;
tryptophan analog;
tyrosine analog |
- 4602. Amifostine/Cisplatin
- (UMLS (NCI) C0280662) =Therapeutic or Preventive Procedure
| - 4652. aminoacid analyzer
- [biomedical equipment or process used to determine the quantities of each individual amino acid in a protein. ( CSP )] (UMLS (CSP) C0179025) =Medical Device =Medical Devices;
|
- 4603. Amifostine/Cisplatin/Cyclophosphamide/Etoposide
- (UMLS (NCI) C0678020) =Therapeutic or Preventive Procedure
| - 4653. aminoacid inhibitor
- [any substance or state which suppresses, prevents, or opposes the action of aminoacids. ( CSP )] (UMLS (CSP) C0596075) =Pharmacologic Substance ;
=inhibitor/antagonist;
|
- 4604. Amifostine/Cisplatin/Cytarabine/Dexamethasone
- (UMLS (NCI) C0677980) =Therapeutic or Preventive Procedure
| - 4654. aminoacid metabolism
- [buildup and breakdown of aminoacids for utilization by the organism. ( CSP )] (UMLS (CSP) C0596076) =Molecular Function ;
=Intermediary Metabolism;
=Amino Acid Biosynthesis;
urea cycle |
- 4605. Amifostine/Cisplatin/Docetaxel
- (UMLS (NCI) C0879412) =Therapeutic or Preventive Procedure
| - 4655. aminoacid oxidase
- [ ] (UMLS (CSP) C0596077) =Amino Acid, Peptide, or Protein; Enzyme =amine oxidoreductase;
|
- 4606. Amifostine/Cisplatin/Etoposide
- (UMLS (NCI) C0280936) =Therapeutic or Preventive Procedure
| - 4656. aminoacid sequence of peptide
- [ ] (UMLS (CSP) C0920679) aminoacid sequence of protein;
peptide sequence =Amino Acid Sequence ;
|
- 4607. Amifostine/Cisplatin/Fluorouracil
- (UMLS (NCI) C0677739) =Therapeutic or Preventive Procedure ;
| - 4657. aminoacid transport
- [movement of aminoacids through a biological system at the cellular level; can be across cell membranes and epithelial layers and also can occur within intracellular compartments and extracellular compartments. ( CSP )] (UMLS (CSP) C0596078) =Cell Function ;
=biological transport;
|
- 4608. Amifostine/Cisplatin/Fluorouracil/Paclitaxel
- (UMLS (NCI) C0796643) =Therapeutic or Preventive Procedure
| - 4658. aminoacid tRNA ligase
- [A subclass of enzymes that aminoacylate AMINO ACID-SPECIFIC TRANSFER RNA with their corresponding AMINO ACIDS. ( MSH )] (UMLS (CSP) C0002529) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 4609. Amifostine/Cisplatin/Gemcitabine
- (UMLS (NCI) C0677827) =Therapeutic or Preventive Procedure ;
| - 4659. aminoacyl fatty acid
- [ ] (UMLS (CSP) C0598431) =Lipid ;
|
- 4610. Amifostine/Cisplatin/Interleukin-2
- (UMLS (NCI) C0280272) =Therapeutic or Preventive Procedure
| - 4660. aminoacyl nucleotide
- [ ] (UMLS (CSP) C0598999) =Nucleic Acid, Nucleoside, or Nucleotide ;
|
- 4611. Amifostine/Cisplatin/Irinotecan
- (UMLS (NCI) C0879428) =Therapeutic or Preventive Procedure
| - 4661. aminoacyl tRNA
- [intermediates in protein biosynthesis; the compounds are formed from amino acids, ATP and transfer RNA, a reaction catalyzed by aminoacyl tRNA synthetase; they are key compounds in the genetic translation process. ( CSP )] (UMLS (CSP) C0035714) =Nucleic Acid, Nucleoside, or Nucleotide; Amino Acid, Peptide, or Protein; Biologically Active Substance =transfer RNA;
|
- 4612. Amifostine/Cisplatin/Monoclonal Antibody R24
- (UMLS (NCI) C0279401) =Therapeutic or Preventive Procedure
| - 4662. Aminoacyl-tRNA Biosynthesis
- (UMLS (NCI) C1510867) Aminoacyl-tRNA Biosynthesis Pathway;
=Conceptual Entity ;
|
- 4613. Amifostine/Cisplatin/Paclitaxel
- (UMLS (NCI) C0677679) =Therapeutic or Preventive Procedure
| - 4663. aminoacyltransferase
- [Enzymes that catalyze the transfer of an aminoacyl group from donor to acceptor resulting in the formation of an ester or amide linkage. EC 2.3.2. ( MSH )] (UMLS (CSP) C0524998) =Amino Acid, Peptide, or Protein; Enzyme =Acetyltransferase;
=glutamyltransferase;
|
- 4614. Amifostine/Cyclophosphamide
- (UMLS (NCI) C0281278) =Therapeutic or Preventive Procedure
| - 4664. aminoazobenzene
- [ ] (UMLS (CSP) C0178473) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
|
- 4615. Amifostine/Cyclophosphamide/Doxorubicin/Paclitaxel
- (UMLS (NCI) C0796660) =Therapeutic or Preventive Procedure
| - 4665. aminobenzene
- [compounds containing a benzene ring and an amine group. ( CSP )] (UMLS (CSP) C0003036) =Organic Chemical; Hazardous or Poisonous Substance
|
- 4616. Amifostine/Cyclophosphamide/Mitoxantrone/Thiotepa
- (UMLS (NCI) C0677770) =Therapeutic or Preventive Procedure
| - 4666. Aminobenzoate Potassium
- [The potassium salt form of aminobenzoate, with anti-inflammatory and antifibrotic activities. Aminobenzoate potassium increases oxygen uptake at the tissue level and may enhance monoamine oxidase (MAO) activity, which requires oxygen as a substrate. Enhanced MAO activity maybe accountable for the prevention or regression of fibrosis, which may occur due to too much serotonin or too little MAO activity. ( NCI )] (UMLS (NCI) C0543464) =Organic Chemical; Pharmacologic Substance =[DE890] DERMATOLOGICALS, SYSTEMIC OTHER;
Unclassified Ingredients;
Inactive Ingredient Preparations;
=POTASSIUM PARA-AMINOBENZOATE 100 GM;
POTASSIUM PARA-AMINOBENZOATE 0.5 GM;
POTASSIUM PARA-AMINOBENZOATE 0.3 GM;
POTASSIUM PARA-AMINOBENZOATE 2 GM;
|
- 4617. Amifostine/Cytarabine/Idarubicin
- (UMLS (NCI) C0678038) =Therapeutic or Preventive Procedure ;
| - 4667. Aminoblastin
- (UMLS (NCI) C1510868) =Organic Chemical; Pharmacologic Substance
|
- 4618. Amifostine/Cytarabine/Mitoxantrone
- (UMLS (NCI) C0678101) =Therapeutic or Preventive Procedure
| - 4668. aminobutyrate
- [aliphatic four carbon acids or their salts, substituted in any position with amino groups. ( CSP )] (UMLS (CSP) C0178474) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
=aa;
=gamma aminobutyrate;
|
- 4619. Amifostine/Cytarabine/Topotecan
- (UMLS (NCI) C0796610) ARA-C/TOPO/WR-2721 =Therapeutic or Preventive Procedure
| - 4669. Aminochlorambucil
- (UMLS (NCI) C0607323) =Organic Chemical ;
|
- 4620. Amifostine/Epoetin Alfa
- (UMLS (NCI) C0796335) EPO/WR-2721;
=Therapeutic or Preventive Procedure | - 4670. aminocyclopentane carboxylate
- [ ] (UMLS (CSP) C0598256) =Amino Acid, Peptide, or Protein
|
- 4621. Amifostine/Etoposide
- (UMLS (NCI) C0796465) VP-16/WR-2721;
=Therapeutic or Preventive Procedure | - 4671. Aminoethylene
- [saturated, 3-membered organic ring system with 1 nitrogen heteroatom. ( CSP )] (UMLS (NCI) C0052794) =Organic Chemical ;
=nitrogenous heterocyclic compound;
=1,1',1"-phosphinothioylidynetrisaziridine |
- 4622. Amifostine/Fludarabine
- (UMLS (NCI) C0677844) =Therapeutic or Preventive Procedure ;
| - 4672. aminoformamidine
- [ ] (UMLS (CSP) C0598539) =Organic Chemical ;
|
- 4623. Amifostine/Irinotecan
- (UMLS (NCI) C0678000) =Therapeutic or Preventive Procedure
| - 4673. Aminoformamidine Hydrochloride
- [The hydrochloride salt form of guanidine, a strong basic compound with parasympathomimetic activity. Guanidine hydrochloride enhances the release of acetylcholine following a nerve impulse and potentiates acetylcholine actions on muscarinic and nicotinic receptors. It also appears to slow the rates of depolarization and repolarization of muscle cell membranes. (NCI05) ( NCI )] (UMLS (NCI) C0120447) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance =Guanidine;
[AU300] PARASYMPATHOMIMETICS (CHOLINERGICS);
TO BE DELETED INGREDIENT PREPARATIONS;
=GUANIDINE HYDROCHLORIDE 125 MG;
|
- 4624. Amifostine/Melphalan
- (UMLS (NCI) C0281015) =Therapeutic or Preventive Procedure
| - 4674. Aminoglutethimide/Hydrocortisone/Suramin
- (UMLS (NCI) C1510871) Suramin/AGT/HC;
=Therapeutic or Preventive Procedure ;
|
- 4625. Amifostine/Mitomycin
- (UMLS (NCI) C0280865) =Therapeutic or Preventive Procedure ;
| - 4675. Aminoglycoside Agents
- [any of a group of antibiotics derived from various species of Streptomyces or produced synthetically; they inhibit protein synthesis by binding with the 30S ribosomal subunit. ( CSP )] (UMLS (NCI) C0003233) =Carbohydrate; Antibiotic
|
- 4626. Amifostine/Paclitaxel
- (UMLS (NCI) C0338346) =Therapeutic or Preventive Procedure ;
| - 4676. aminoguanidine
- [diamine oxidase and nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications. ( CSP )] (UMLS (CSP) C0282774) =Organic Chemical; Pharmacologic Substance ;
=Guanidines;
|
- 4627. Amifostine/Thiotepa
- (UMLS (NCI) C0280275) =Therapeutic or Preventive Procedure
| - 4677. aminohydrolase
- [ ] (UMLS (CSP) C0002559) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 4628. Amifostine/Topotecan
- (UMLS (NCI) C0677737) =Therapeutic or Preventive Procedure ;
| - 4678. aminolevulinate dehydratase
- [An enzyme that catalyzes the formation of porphobilinogen from two molecules of 5-aminolevulinic acid. EC 4.2.1.24. ( MSH )] (UMLS (CSP) C0002564) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 4629. AMIKACIN
- [An antibiotic drug used to treat infection. It belongs to the family of drugs called aminoglycoside antibiotics. ( NCI )] (UMLS (NCI) C0002499) =Carbohydrate; Antibiotic
| - 4679. aminopeptidase
- [A subclass of EXOPEPTIDASES that act on the free N terminus end of a polypeptide liberating a single amino acid residue. EC 3.4.11. ( MSH )] (UMLS (CSP) C0002570) =Amino Acid, Peptide, or Protein; Enzyme
|
- 4630. Amikacin/Ceftazidime
- (UMLS (NCI) C0280693) =Therapeutic or Preventive Procedure
| - 4680. aminopeptidase N
- [Zinc-binding metalloproteases that are members of the type II integral membrane metalloproteases. They are expressed by GRANULOCYTES; MONOCYTES; and their precursors as well as by various non-hematopoietic cells. They release an N-terminal amino acid from a peptide, amide or arylamide. ( MSH )] (UMLS (CSP) C0054943) =Amino Acid, Peptide, or Protein; Enzyme; Immunologic Factor
|
- 4631. Amikacin/Ceftriaxone
- (UMLS (NCI) C0280694) =Therapeutic or Preventive Procedure
| - 4681. aminophosphonate
- [phosphonic acid, HPO(OH)2, or its salt, anion, or ester, with an amino group attached. ( CSP )] (UMLS (CSP) C0596079) =Inorganic Chemical ;
=phosphonate;
|
- 4632. Amikin
- (UMLS (NCI) C0700949) =Carbohydrate; Antibiotic ;
| - 4682. Aminophosphonate Metabolism
- (UMLS (NCI) C1510872) Aminophosphonate Metabolism Pathway;
=Molecular Function ;
|
- 4633. amiloride
- [pyrazine compound inhibiting sodium reabsorbtion through sodium channels in renal epithelial cells; used in conjunction with diuretics to spare potassium loss. ( CSP )] (UMLS (CSP) C0002502) =Organic Chemical; Pharmacologic Substance ;
| - 4683. Aminopterin Sodium
- (UMLS (NCI) C0282048) =Organic Chemical; Hazardous or Poisonous Substance ;
|
- 4634. aminacrine
- [highly fluorescent anti-infective dye used clinically as a topical antiseptic and experimentally as a mutagen, due to its interaction with DNA; it is also used as an intracellular pH indicator. ( CSP )] (UMLS (CSP) C0002536) =Organic Chemical; Pharmacologic Substance ;
| - 4684. Aminopterin/Leucovorin Calcium
- (UMLS (NCI) C0796626) APGA/CF =Therapeutic or Preventive Procedure
|
- 4635. amination
- [creation of an amine by the addition of an amino group to an organic compound or reduction of a nitro group. ( CSP )] (UMLS (CSP) C0002505) =Natural Phenomenon or Process
| - 4685. aminopyridine
- [pyridines substituted in any position with an amino group; may be hydrogenated, but must retain at least one double bond. ( CSP )] (UMLS (CSP) C0002585) =Organic Chemical ;
|
- 4636. amine
- [group of compounds derived from ammonia by substituting organic radicals for the hydrogens. ( CSP )] (UMLS (CSP) C0002508) =Organic Chemical
| - 4686. aminopyrimidine
- [organic compound with a six-sided ring structure that includes two nitrogen atoms attached to an amino group. ( CSP )] (UMLS (CSP) C0596080) =Organic Chemical ;
=Pyrimidine;
=4-Amino-2(1H)-pyrimidinone;
DAP |
- 4637. amine oxidase (copper)
- [A group of enzymes including those oxidizing primary monoamines, diamines, and histamine. They are copper proteins, and, as their action depends on a carbonyl group, they are sensitive to inhibition by semicarbazide. EC 1.4.3.6. ( MSH )] (UMLS (CSP) C0019587) =Amino Acid, Peptide, or Protein; Enzyme =amine oxidoreductase;
| - 4687. Aminosalicylate Sodium
- [The sodium salt form of aminosalicylic acid, an analog of para-aminobenzoic acid (PABA) with antitubercular activity. Aminosalicylate sodium exerts its bacteriostatic activity against Mycobacterium tuberculosis by competing with PABA for enzymes involved in folate synthesis, thereby suppressing growth and reproduction of M. tuberculosis, eventually leading to cell death. ( NCI )] (UMLS (NCI) C0301336) =Organic Chemical; Pharmacologic Substance =AMINOSALICYLATE;
=AMINOSALICYLATE SODIUM 1 GM;
AMINOSALICYLATE SODIUM 500 MG |
- 4638. amine oxidoreductase
- [ ] (UMLS (CSP) C0002507) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 4688. Aminosidine Sulfate
- [The sulfate salt form of paromomycin, a structural derivative of neomycin, an aminoglycoside antibiotic with amebicidal and bactericidal effects against predominantly aerobic gram-negative bacteria. Paromomycin binds specifically to the RNA oligonucleotide at the A site of bacterial 30S ribosomes, thereby causing misreading and premature termination of translation of mRNA and inhibition of protein synthesis followed by cell death. ( NCI )] (UMLS (NCI) C0205881) =Carbohydrate; Antibiotic =PAROMOMYCIN;
=PAROMOMYCIN SULFATE 250 MG;
|
- 4639. amino 3 hydroxy 5 methylisoxazole 4 propionate
- [An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies. ( MSH )] (UMLS (CSP) C0051318) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid
| - 4689. Aminosugars Metabolism
- [The chemical reactions and pathways involving any amino sugar, sugars containing an amino group in place of a hydroxyl group. [GOC:jl, ISBN:0192801023] ( GO )] (UMLS (NCI) C1156862) Aminosugars Metabolism Pathway;
=Molecular Function |
- 4640. Amino Acid Biosynthesis
- [anabolic formation of aminoacids in organisms or living cells and cell extracts. ( CSP )] (UMLS (NCI) C0596074) =Molecular Function ;
=anabolism;
aminoacid metabolism | - 4690. aminosulfonate
- [ ] (UMLS (CSP) C0596081) =Inorganic Chemical ;
|
- 4641. Amino Acid Channel
- [Amino Acid Transporter proteins carry organic compounds containing an amino (-NH2) and a carboxyl (-COOH) group through solubility barriers, such as aqueous body fluids, lipid membranes or across epithelial layers. After binding substrate, transmembrane transporters often undergo an energy-dependent conformational change that moves the substrate across the membrane with (symport) or against (antiport) concentration gradients. ( NCI )] (UMLS (NCI) C0949771) Amino Acid Transporter;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 4691. aminothiol
- [organic compound similar to an alcohol but in which the oxygen atom has been replaced by a sulfur atom and to which an amino group is attached. ( CSP )] (UMLS (CSP) C0596082) =Organic Chemical ;
=amine;
mercaptan =cysteamine;
|
- 4642. Amino Acid Injection
- [A type of nutritional support. It is particularly useful when oral nutrition is unfeasible, impractical or inadequate. ( NCI )] (UMLS (NCI) C0280081) =Clinical Drug
| - 4692. aminotransferase
- [Transaminases are a sub-subclass of mostly pyridoxal phosphate-dependent transferase enzymes that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Mediating conversion of major intermediate metabolites and reversible transamination, Transaminases are often involved in cellular nitrogen metabolism, amino acid metabolism, gluconeogenesis and in the urea and tricarboxylic acid cycles. ( NCI )] (UMLS (CSP) C0002594) =Amino Acid, Peptide, or Protein; Enzyme
|
- 4643. Amino Acid Metabolism - Reference Pathway
- (UMLS (NCI) C1510864) Amino Acid Metabolism Pathway;
=Molecular Function ;
| - 4693. amiodarone
- [2-butyl-3-(3,5-diiodo-4-beta diethylaminoethoxybenzoyl) benzofuran; coronary vasodilator used as an antiarrhythmic; severe risk of pulmonary and hepatic toxicity via disruption of lysosomal function; also has amphiphilic phototoxin properties. ( CSP )] (UMLS (CSP) C0002598) =Organic Chemical; Pharmacologic Substance
|
- 4644. Amino Acid Receptor Binding
- [Amino Acid Receptor Interaction involves non-covalent binding through intermolecular physical forces of attraction with a group of intrinsic membrane proteins that bind to and mediate the biological effects of small organic compounds containing an amino and carboxyl group that act as neurotransmitters (e.g., glutamic acid or aspartic acid) through modification of the activity of signal transduction pathways in target cells. ( NCI )] (UMLS (NCI) C1510865) =Molecular Function ;
| - 4694. amiodarone/DOX
- (UMLS (NCI) C0279280) =Therapeutic or Preventive Procedure ;
|
- 4645. amino acid sequence
- [order of amino acids as they occur in a polypeptide chain. ( CSP )] (UMLS (NCI) C0002518) =Amino Acid Sequence
| - 4695. amiodarone/DOX/VP-16
- (UMLS (NCI) C0279279) =Therapeutic or Preventive Procedure ;
|
- 4646. Amino Acid Synthesis Inhibition
- [Amino Acid Synthesis Inhibition involves interference with, or restraint of, enzymatic formation of organic compounds that contain an amino (-NH2) and a carboxyl (-COOH) group. ( NCI )] (UMLS (NCI) C1510866) =Physiologic Function ;
| - 4696. Amiodarone/VBL
- (UMLS (NCI) C0280651) =Therapeutic or Preventive Procedure
|
- 4647. Amino Acid, Peptide, or Protein
- [Amino acids and chains of amino acids connected by peptide linkages. ( NCI )] (UMLS (NCI) C1254349) =Amino Acid, Peptide, or Protein ;
| - 4697. Amish
- [ ] (UMLS (CSP) C0238622) =Population Group
|
- 4648. amino group
- [monovalent chemical group -NH2. ( CSP )] (UMLS (CSP) C0596072) =Inorganic Chemical ;
=chemical group;
| - 4698. amitosis
- [Nuclear division that occurs by simple constriction of the nucleus without chromosome condensation or spindle formation. [http://cancerweb.ncl.ac.uk/, ISBN:0721662544] ( GO )] (UMLS (CSP) C0598083) =Cell Function ;
|
- 4649. AMINO-ACID TRANSPORT DIS
- (UMLS (ICD9CM) C0268641) =Disease or Syndrome
| - 4699. amitriptyline
- [tricyclic antidepressant with anticholinergic and sedative properties; it appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters; it also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines. ( CSP )] (UMLS (CSP) C0002600) =Organic Chemical; Pharmacologic Substance
|
- 4650. Amino-Arginine
- [An amino acid derivative. As an analog of arginine, amino-arginine competes with the normal substrate arginine and binds to the heme of the NOS as a false substrate, thereby inhibiting endothelial and inducible nitric oxide synthases (eNOS / NOS III and iNOS / NOS II). Arginine is the only physiological substrate for NOS which, in eukaryotic cells, generates NO and L-citrulline from L-arginine and molecular oxygen in a five-electron transfer reaction. This clinical use of amino-arginine is limited due to its epileptogenic properties. (NCI04) ( NCI )] (UMLS (NCI) C1510863) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 4700. AMLODIPINE
- [A synthetic dihydropyridine and a calcium channel blocker with antihypertensive and antianginal properties. Amlodipine inhibits the influx of extracellular calcium ions into myocardial and peripheral vascular smooth muscle cells, thereby preventing vascular and myocardial contraction. This results in a dilatation of the main coronary and systemic arteries, decreases myocardial contractility, increases blood flow and oxygen delivery to the myocardial tissue and decreases total peripheral resistance. This agent may also modulate multi-drug response (MDR) activity through inhibition of the p-glycoprotein efflux pump. ( NCI )] (UMLS (NCI) C0051696) =Organic Chemical; Pharmacologic Substance =antihypertensive agent;
[CV200] CALCIUM CHANNEL BLOCKERS;
Dihydropyridines;
[CV250] ANTIANGINALS =AMLODIPINE BESYLATE |
home 
Armenian-English 
top